Showing results (1-10 of 26) with videos related to
Sort By:
Pageof 3
Antioxidants (Basel, Switzerland)|January 26, 2019
Signals Getting Crossed in the Entanglement of Redox and Phosphorylation Pathways: Phosphorylation of Peroxiredoxin Proteins Sparks Cell SignalingJohn J Skoko, Shireen Attaran, Carola A NeumannAntioxidants & Redox Signaling|December 15, 2017
Peroxiredoxin Involvement in the Initiation and Progression of Human CancerMark B Hampton, Kate A Vick, John J Skoko, et al.Antioxidants & Redox Signaling|April 7, 2010
When NRF2 talks, who's listening?Nobunao Wakabayashi, Stephen L Slocum, John J Skoko, et al.Bioorganic & Medicinal Chemistry|June 20, 2006
Biological evaluation of newly synthesized quinoline-5,8-quinones as Cdc25B inhibitorsJanine Cossy, Damien Belotti, Marni Brisson, et al.Scientific Reports|March 29, 2019
Author Correction: Mimicking Embedded Vasculature Structure for 3D Cancer on a Chip Approaches through MicromillingL Wan, J Skoko, J Yu, et al.Scientific Reports|December 3, 2017
Mimicking Embedded Vasculature Structure for 3D Cancer on a Chip Approaches through MicromillingL Wan, J Skoko, J Yu, et al.BMC Cancer|August 18, 2019
The peroxidase PRDX1 inhibits the activated phenotype in mammary fibroblasts through regulating c-Jun N-terminal kinasesAgnieszka Jezierska-Drutel, Shireen Attaran, Barbara L Hopkins, et al.Bioorganic & Medicinal Chemistry|May 16, 2006
Novel benzofuran inhibitors of human mitogen-activated protein kinase phosphatase-1John S Lazo, Ruth Nunes, John J Skoko, et al.Archives of Biochemistry and Biophysics|December 25, 2015
Keap1/Nrf2 pathway activation leads to a repressed hepatic gluconeogenic and lipogenic program in mice on a high-fat dietStephen L Slocum, John J Skoko, Nobunao Wakabayashi, et al.Molecular Cancer Therapeutics|February 5, 2008
A cell-active inhibitor of mitogen-activated protein kinase phosphatases restores paclitaxel-induced apoptosis in dexamethasone-protected cancer cellsAndreas Vogt, Peter R McDonald, Aletheia Tamewitz, et al.Pageof 3